CHICAGO, July 6 /PRNewswire/ — ICAP Ocean Tomo,
the intellectual property brokerage division of ICAP plc (IAP.L),
has been engaged to sell a patent portfolio of near-infrared
spectroscopy technology owned by NIResults Inc. The portfolio
includes over 90 issued US and foreign patents and patent
applications. The assets have been cited by over 20 companies
including Abbott Laboratories, Baxter International, Bayer
Healthcare, Beckman Coulter Inc., Xerox, and Hewlett Packard.
(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20100614/CG20517LOGO)
The patents of this portfolio cover the use of near-infrared
spectroscopy in clinical chemistry analysis systems, pulse
oximeters and CO-oximeters, non-invasive glucose monitors, and
hemoglobin monitors. The patents describe a method for the
monitoring of key blood analytes without the need for costly,
environmentally challenging, chemical reagents. The assets also
include in-vitro, which is applied to a droplet of blood from a
sample, and in-vivo (non-invasive) tech
‘/>”/>
SOURCE